Simplified regimen for the prevention of paclitaxel-associated hypersensitivity reactions

被引：21
|
作者：
Markman, M [1 ]
Kennedy, A [1 ]
Webster, K [1 ]
Peterson, G [1 ]
Kulp, B [1 ]
Belinson, J [1 ]
机构：
[1] CLEVELAND CLIN FDN,CLEVELAND,OH 44195
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1997年 / 15卷 / 12期
关键词：
D O I：
10.1200/JCO.1997.15.12.3517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3517 / 3517
页数：1
相关论文
共 50 条
  • [21] Can pregabalin prevent paclitaxel-associated neuropathy?-An ACCRU pilot trial
    Shinde, Shivani S.
    Seisler, Drew
    Soori, Gamini
    Atherton, Pamela J.
    Pachman, Deirdre R.
    Lafky, Jacqueline
    Ruddy, Kathryn J.
    Loprinzi, Charles L.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (02) : 547 - 553
  • [22] The administration of paclitaxel without prophylaxis for the prevention of hypersensitivity reactions: is this a rationale and safe therapeutic strategy?
    Maurie Markman
    Journal of Cancer Research and Clinical Oncology, 1997, 123 : 531 - 532
  • [23] The administration of paclitaxel without prophylaxis for the prevention of hypersensitivity reactions: is this a rationale and safe therapeutic strategy?
    Markman, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (10) : 531 - 532
  • [24] Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles
    Shiozaki, Afonso A.
    Senra, Tiago
    Morikawa, Aleksandra T.
    Deus, Debora F.
    Paladino-Filho, Antonio T.
    Pinto, Ibraim M. F.
    Maranhao, Raul C.
    CLINICS, 2016, 71 (08) : 435 - 439
  • [25] A randomized double-blind feasibility study comparing cetirizine and diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions: the PREMED-F1 study
    Beaucage-Charron, Johannie
    Gaudet, Laurence
    Lamothe, Sarah
    Pelletier, Cloe
    Pepin, Anne-Sophie
    Roy, Valerie
    Charpentier, Frederic
    Lordkipanidze, Marie
    Projean, Denis
    Bouchard, Philippe
    Picard, Matthieu
    SUPPORTIVE CARE IN CANCER, 2022, 30 (04) : 3389 - 3399
  • [26] Can pregabalin prevent paclitaxel-associated neuropathy?—An ACCRU pilot trial
    Shivani S. Shinde
    Drew Seisler
    Gamini Soori
    Pamela J. Atherton
    Deirdre R. Pachman
    Jacqueline Lafky
    Kathryn J. Ruddy
    Charles L. Loprinzi
    Supportive Care in Cancer, 2016, 24 : 547 - 553
  • [27] A randomized double-blind feasibility study comparing cetirizine and diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions: the PREMED-F1 study
    Johannie Beaucage-Charron
    Laurence Gaudet
    Sarah Lamothe
    Cloé Pelletier
    Anne-Sophie Pépin
    Valérie Roy
    Frédéric Charpentier
    Marie Lordkipanidzé
    Denis Projean
    Philippe Bouchard
    Matthieu Picard
    Supportive Care in Cancer, 2022, 30 : 3389 - 3399
  • [28] A Randomized Controlled Trial Plus a Systematic Review and Meta-Analysis of Published Studies Evaluating a Conventional Prophylactic Regimen of Oral Dexamethasone vs Short-Course Intravenous Dexamethasone in Preventing Paclitaxel-Associated Hypersensitivity Reactions in Patients With Gynecologic Malignancies
    Donkor, Kofi N.
    Jang, Hyeree
    Selim, Julie Hana
    Ioffe, Yevgeniya J.
    Hong, Linda J.
    ANNALS OF PHARMACOTHERAPY, 2025,
  • [29] Efficacy of additional dexamethasone administration for the attenuation of paclitaxel-associated acute pain syndrome
    Yoshitaka Saito
    Masaki Kobayashi
    Takehiro Yamada
    Jun Sakakibara-Konishi
    Naofumi Shinagawa
    Ichiro Kinoshita
    Hirotoshi Dosaka-Akita
    Ken Iseki
    Supportive Care in Cancer, 2020, 28 : 221 - 227
  • [30] Ovariectomy aggravates hypersensitivity reactions to paclitaxel in rats
    Goromaru, T
    Itoh, Y
    Sendo, T
    Kobayashi, K
    Yano, T
    Ikesue, H
    Oishi, R
    CANCER BIOLOGY & THERAPY, 2005, 4 (02) : 225 - 230
12345